PTTG and cancer

Histology and Histopathology

Volumn 18, Issue 1, 2003, Pages 245-251

  Hamid, T ^b   Kakar, Sham S ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Oncogene; Pituitary; PTTG; Tumor; Tumorigenesis

Indexed keywords

AMINO ACID; PROTEIN; UBIQUITIN;

AMINO ACID SEQUENCE; CARCINOGENESIS; CELL CLONING; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; DNA BINDING; GENE EXPRESSION; GENE ISOLATION; HYPOPHYSIS TUMOR; IN VITRO STUDY; MOLECULAR MECHANICS; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; ONCOGENE; PROTEIN DEGRADATION; PROTEIN DOMAIN; REVIEW; SEQUENCE HOMOLOGY; TRANSACTIVATION; TUMOR GROWTH; TUMOR MODEL;

AMINO ACID SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PITUITARY NEOPLASMS;

MUS MUSCULUS;

EID: 2442605030     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Alexander J.M., Biller B.M., Bikkal H., Zervas N.T., Arnold A. and Klibanski A. (1990). Clinically nonfunctioning pituitary tumors are monoclonal in origin. J. Clin. Invest. 86, 336-340.
2. Chen L., Puri R., Lefkowitz E.J. and Kakar S.S. (2000). Identification of the human pituitary tumor transforming gene (hPTTG) family: Molecular structure, expression, and chromosomal localization. Gene 248, 41-50.
3. Chien W. and Pei L. (2000). A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product. J. Biol. Chem. 275, 19422-19427.
4. Dominguez A., Ramos-Morales F., Romero F., Rios R.M., Dreyfus F. and Tortolero M., Pintor-Toro J.A. (1998). hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG. Oncogene, 17, 2187-2193.
5. Featherstone C. and Jackson S.P. (1999). Ku, a DNA repair protein with multiple cellular functions? Mutat. Res. 434, 3-15.
6. Funabiki H., Kumada K. and Yanagida M. (1996). Fission yeast Cut1 and Cut2 are essential for sister chromatid separation, concentrate along the metaphase spindle and form large complexes. EMBO. J. 15, 6617-6628.
7. Heaney A.P. and Melmed S. (2000). New pituitary oncogenes. Endocr. Relat. Cancer 7, 3-15.
8. Heaney A.P., Horwitz G.A., Wang Z., Singson R. and Melmed S. (1999). Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat. Med. 5, 1317-1321.
9. Heaney A.P., Singson R., McCabe C.J., Nelson V., Nakashima M. and Melmed S. (2000). Expression of pituitary-tumour transforming gene in colorectal tumors. Lancet. 355, 716-719.
10. Henriksson M. and Luscher B. (1996). Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv. Cancer Res. 68, 109-182.
11. Kakar S.S. (1999). Molecular cloning, genomic organization, and identification of the promoter for the human pituitary tumor transforming gene (PTTG). Gene 29, 317-324.
12. Kakar S.S. and Jennes L. (1999). Molecular cloning and characterization of the tumor transforming gene (TUTR1): A novel gene in human tumorigenesis. Cytogenet. Cell Genet. 84, 211-216.
13. Kakar S.S., Chen L., Puri R., Flynn S.E. and Jennes L. (2001). Characterization of a polyclonal antibody to human pituitary tumor transforming gene 1 (PTTG1) protein. J. Histochem. Cytochem. 49, 1537-1546.
14. Pei L. (1998). Genomic organization and identification of an enhancer element containing binding sites for multiple proteins in rat pituitary tumor-transforming gene. J. Biol. Chem. 273, 5219-5225.
15. Pei L. (2000). Activation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene transactivation function. J. Biol. Chem. 275, 31191-31198.
16. Pei L. (2001). Identification of c-myc as a down-stream target for pituitary tumor-transforming gene. J. Biol. Chem. 276, 8484-8491.
17. Pei L. and Melmed S. (1997). Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol. Endocrinol. 11, 433-441.
18. Prezant T.R., Kadioglu P. and Melmed S. (1999). An intronless homolog of human proto-oncogene hPTTG is expressed in pituitary tumors: Evidence for hPTTG family. J. Clin. Endocrinol. Metab. 84, 1149-1152.
19. Ptashne M. and Gann A. (1998). Imposing specificity by localization: Mechanism and evolvability. Curr. Biol. 8, R897.
20. Puri R., Tousson A., Chen L. and Kakar S.S. (2001). Molecular cloning of pituitary tumor transforming gene 1 from ovarian tumors and its expression in tumors. Cancer Lett. 163, 131-139.
21. Ramos-Morales F., Dominguez A., Romero F., Luna R., Multon M.C. and Pintor-Toro J.A. (2000). Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product. Oncogene 19, 403-409.
22. Ray D. and Melmed S. (1997). Pituitary cytokine and growth factor expression and action. Endocr. Rev. 18, 206-228.
23. Romero F., Multon M.C., Ramos-Morales F., Dominguez A., Bernal J.A., Pintor-Toro J.A. and Tortolero M. (2001). Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase. Nucleic Acids Res. 29, 1300-1307.
24. Shimon I. and Melmed S. (1997). Genetic basis of endocrine disease: Pituitary tumor pathogenesis. J. Clin. Endocrinol. Metab. 82, 1675-1681.
25. Wang Z., Yu R. and Melmed S. (2001). Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Mol. Endocrinol. 15, 1870-1879.
26. Yu R., Ren S.G., Horwitz G.A., Wang Z. and Melmed S. (2000). Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: Evidence from live cell imaging. Mol. Endocrinol. 14, 1137-1146.
27. Zhang X., Horwitz G.A., Prezant T.R., Valentini A., Nakashima M., Bronstein M.D. and Melmed S. (1999). Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol. Endocrinol. 13, 156-166.
28. Zou H., McGarry T.J., Bernal T. and Kirschner M.W. (1999). Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285, 418-422.
29. Zur A. and Brandeis M. (2001). Securin degradation is mediated by fzy and fzr, and is required for complete chromatid separation but not for cytokinesis. EMBO J. 20, 792-801.